stockrowElanco Animal Health Incorporated
ELAN Healthcare Drug Manufacturers Specialty & Generic
Elanco Animal Health Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $4.7 billion, up 6.22% from fiscal 2024.
- Revenue
- +10.2%
- EPS
- +450.0%
- Free cash flow
- +35.6%
- Total debt
- −6.91%
Quarter to June 2026, against a year earlier
Follow ELAN
Alert me
Elanco Animal Health Incorporated (ELAN) Net margin
Elanco Animal Health Incorporated's net margin over the twelve months to 30 June 2026 was −3.96%, up 1.0 percentage points from fiscal 2025 (−4.92%). Over the past ten years it has ranged from −27.9% (fiscal 2023) to 7.61% (fiscal 2024); the current reading is higher than 55% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of −2.45% and below the Healthcare sector median of 0.00%.
Net margin, annual
Embed this chart
Annual newest first
| Period | Net margin | Change (points) |
|---|---|---|
| FY2025 | −4.92% | (12.53) |
| FY2024 | 7.61% | 35.48 |
| FY2023 | −27.9% | (26.10) |
| FY2022 | −1.77% | 8.37 |
| FY2021 | −10.1% | 7.41 |
| FY2020 | −17.6% | (19.76) |
| FY2019 | 2.21% | (0.61) |
| FY2018 | 2.82% | 13.57 |
| FY2017 | −10.8% | (9.11) |
| FY2016 | −1.64% | 5.61 |
Quarterly newest first
| Period | Net margin | Change (points) |
|---|---|---|
| Jun 2026 | 3.95% | (0.21) |
| Mar 2026 | 4.16% | 28.29 |
| Dec 2025 | −24.1% | (21.14) |
| Sep 2025 | −2.99% | (3.88) |
| 31 more quarters | Free account |
Against its own ten years
Net margin against peers
| Company | Net margin |
|---|---|
| NBIX Neurocrine Biosciences, Inc. compare | 19.0% |
| LNTH Lantheus Holdings, Inc. compare | 17.3% |
| KNSA Kiniksa Pharmaceuticals International, plc compare | 11.6% |
| RDY Dr. Reddy's Laboratories Ltd compare | 8.06% |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | 4.17% |
| ALKS Alkermes plc compare | −0.02% |
| ELAN Elanco Animal Health Incorporated | −3.96% |
| VTRS Viatris Inc. compare | −4.13% |
| HIMS Hims & Hers Health, Inc. compare | −5.51% |
| Drug Manufacturers Specialty & Generic industry median | −2.45% |
| Healthcare sector median | 0.00% |
| Market median | 1.06% |
What Net margin is
Net Profit Margin tells an investor how much of each unit of revenue ends up as profit for shareholders after all costs, interest and taxes.
Net Income Allotted to Shareholders ÷ Revenue
More on ELAN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement